I continue to believe that the healthcare sector is a great place to invest with a long term view.
This is due to favourable industry tailwinds which look set to support demand for healthcare services for a long time to come.
While I think CSL Limited (ASX: CSL) would be a strong buy right now for this reason, it isn’t the only healthcare share to consider.
Here are two exciting ASX healthcare shares to look at:
Opthea is a developer of novel biologic therapies for the treatment of eye diseases. The key attraction to the company for me is the OPT-302 combination therapy which delivered very strong study results last year. If its upcoming Phase 3 trial proves just as successful, then the future could be very bright for the…